Side effects of 5-day radiation
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of 5-Day Radiation Therapy
Introduction to 5-Day Radiation Therapy
Radiation therapy is a common treatment for various cancers, often combined with chemotherapy agents like 5-fluorouracil (5-FU). A 5-day radiation therapy regimen involves administering radiation over a short period, typically in conjunction with chemotherapy, to enhance the treatment's effectiveness. However, this approach can lead to several side effects, which vary in severity and type.
Common Side Effects of 5-Day Radiation Therapy
Gastrointestinal Toxicity
One of the most frequently reported side effects of 5-day radiation therapy, especially when combined with 5-FU, is gastrointestinal toxicity. In a study involving 41 patients treated with protracted venous infusion of 5-FU and conventionally fractionated radiation therapy, 95% of patients experienced mild to moderate toxicity, while 5% had severe gastrointestinal side effects that necessitated cessation of therapy . This indicates that while the treatment is generally tolerable, there is a risk of significant gastrointestinal complications.
Hematologic Toxicity
Hematologic toxicity is another critical side effect observed in patients undergoing 5-day radiation therapy. In a phase II trial involving high-dose radiation therapy combined with 5-FU and cisplatin for anal cancer, 15 out of 19 patients experienced Grade 3 or higher toxicity, with hematologic toxicity being the most common severe side effect . This highlights the need for careful monitoring of blood counts and supportive care to manage these toxicities.
Mucositis and Weight Loss
Severe mucositis and significant weight loss are also prevalent among patients receiving 5-day radiation therapy. In a study of patients with head and neck cancer treated with simultaneous cisplatin, 5-FU, and radiation, 48% experienced severe mucositis, and 53% had a weight loss of 10% or more . These side effects can severely impact the patient's quality of life and may require nutritional support and pain management.
Proctitis
Radiation-induced proctitis is a specific side effect observed in patients undergoing radiotherapy for prostate carcinoma. A study investigating the prophylactic use of mesalazine (5-ASA) suppositories found that 75% of patients treated with 5-ASA reported severe proctitis, compared to only one patient in the placebo group . This suggests that certain interventions intended to mitigate side effects may not always be effective and can sometimes exacerbate the condition.
Conclusion
While 5-day radiation therapy combined with chemotherapy agents like 5-FU can be effective in treating various cancers, it is associated with several side effects, including gastrointestinal toxicity, hematologic toxicity, severe mucositis, weight loss, and proctitis. These side effects necessitate careful patient monitoring and supportive care to manage and mitigate their impact. Further research and clinical trials are essential to optimize treatment protocols and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic
[Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
Mesalazine suppositories are not useful in preventing radiation-induced proctitis during prostate cancer radiotherapy due to severe side effects.
5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma.
Combining 5-Fluorouracil (5FU) infusions with radiation produces an additive tumor response, with regrowth delay dependent on the total dose of 5FU.
Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT.
Higher radiation doses in prostate cancer treatment may increase survival rates, but randomized trials are needed for clear proof of dose-response relationships.
The time course of development of late side effects after irradiation of the prostate with multiple fractions per day.
Multiple fractions per day (MFD) irradiation of prostate cancer led to an unacceptable high incidence of late side effects, highlighting the need for sufficient follow-up time in pelvic tumor research.
DOI